miRNAs as biomarkers of neurodegenerative disorders

被引：60

作者：

Viswambharan, Vijitha ^{[1
]}

Thanseem, Ismail ^{[1
]}

Vasu, Mahesh M. ^{[2
]}

Poovathinal, Suresh A. ^{[3
]}

Anitha, Ayyappan ^{[1
]}

机构：

[1] Inst Communicat & Cognit Neurosci ICCONS, Dept Neurogenet, Palakkad 679523, Kerala, India

[2] Hamamatsu Univ, Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan

[3] Inst Communicat & Cognit Neurosci ICCONS, Dept Neurol, Palakkad 679523, Kerala, India

来源：

BIOMARKERS IN MEDICINE | 2017年 / 11卷 / 02期

关键词：

Alzheimer's disease; amyotrophic lateral sclerosis; Friedreich's ataxia; Huntington's disease; miRNA; multiple sclerosis; Parkinson's disease; prion disease; spinal muscular atrophy; spinocerebellar ataxia; MULTIPLE-SCLEROSIS PATIENTS; MICRORNA EXPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CIRCULATING MICRORNAS; FRIEDREICH ATAXIA; GENETIC-ANALYSIS; BARRIER FUNCTION; RNA EXPRESSION; UP-REGULATION;

D O I：

10.2217/bmm-2016-0242

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Neurodegenerative diseases (NDDs) are the result of progressive deterioration of neurons, ultimately leading to disabilities. There is no effective cure for NDDs at present; ongoing therapies are mainly aimed at treating the most bothersome symptoms. Since early treatment is crucial in NDDs, there is an urgent need for specific and sensitive biomarkers that can aid in early diagnosis of these disorders. Recently, altered expression of miRNAs has been implicated in several neurological disorders, including NDDs. miRNA expression has been extensively investigated in the cells, tissues and body fluids of patients with different types of NDDs. The aim of this review is to provide a comprehensive overview of miRNAs as biomarkers and therapeutic targets for NDDs.

引用

页码：151 / 167

页数：17

共 50 条

[31] Biomarkers for major depression and its delineation from neurodegenerative disorders
Schneider, Barbara
Prvulovic, David
Oertel-Knoechel, Viola
Knoechel, Christian
Reinke, Britta
Grexa, Martin
Weber, Bernhard
Hampel, Harald
PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 703 - 717
[32] METALLOTHIONEINS AS EARLY AND SENSITIVE BIOMARKERS OF REDOX SIGNALING IN NEURODEGENERATIVE DISORDERS
Sharma, Sushil
Ebadi, Manuchair
IIOAB JOURNAL, 2011, 2 (06) : 98 - 106
[33] Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C
Korolenko, T. A.
Pupyshev, A. B.
Belichenko, V. M.
Tikhonova, M. A.
Amstislavskaya, T. G.
NEUROCHEMICAL JOURNAL, 2023, 17 (04) : 509 - 515
[34] How far can biomarkers take us in neurodegenerative disorders?
Husain, Masud
BRAIN, 2017, 140 : 3067 - 3068
[35] The path of neurodegenerative disorders. From molecular mechanisms to biomarkers
Oliveira, C. R.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 25 - 25
[36] Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
Maass, Fabian
Lingor, Paul
NEURAL REGENERATION RESEARCH, 2018, 13 (08) : 1356 - 1357
[37] MicroRNAs (miRNAs) in neurodegenerative diseases
Nelson, Peter T.
Wang, Wang-Xia
Rajeev, Bernard W.
BRAIN PATHOLOGY, 2008, 18 (01) : 130 - 138
[38] The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
Paraskevas, George P.
BRAIN SCIENCES, 2022, 12 (05)
[39] Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders
Kim, Sung-Woo
Song, Yeong-Hun
Kim, Hee Jin
Noh, Young
Seo, Sang Won
Na, Duk L.
Seong, Joon-Kyung
FRONTIERS IN NEUROSCIENCE, 2022, 16
[40] Are miRNAs suitable as Biomarkers?
Ross, Linda Sarah
Goette, Martin
Kiesel, Ludwig
GYNAKOLOGISCHE ENDOKRINOLOGIE, 2018, 16 (03): : 205 - 208

← 1 2 3 4 5 →